Skip to main content

Table 5 Regression of basal lipolysis and responsiveness to adrenoceptor agonist on ERS1 mRNA levels

From: Impact of estrogen receptor gene polymorphisms and mRNA levels on obesity and lipolysis – a cohort study

 

Coefficient ± SE

Std. Coeff.

T-value

P value

Basal lipolysis

    

Intercept

2.34 ± 4.54

2.34

0.51

0.61

ESR1 (AU)

-3.90 ± 1.62

-0.20

-2.40

0.018

BMI (kg/m2)

0.44 ± 0.10

0.39

4.61

<0.0001

Age (years)

-0.14 ± 0.08

-0.15

-1.86

.065

Response to noradrenaline

    

Intercept

13.84 ± 6.40

13.84

2.16

.033

ESR1 (AU)

-5.72 ± 2.26

-0.21

-2.53

.013

BMI (kg/m2)

0.58 ± 0.13

0.37

4.38

<0.0001

Age (years)

-0.22 ± 0.11

-.174

-2.12

.036

Response to isoprenaline

    

Intercept

15.44 ± 8.72

15.44

1.77

0.079

ESR1 (AU)

-6.31 ± 3.11

-0.18

-2.03

0.045

BMI (kg/m2)

0.78 ± 0.18

0.37

4.28

<.0001

Age (years)

-0.16 ± 0.14

-0.10

-1.14

0.26

Response to clonidine

    

Intercept

0.99 ± 0.92

0.99

1.08

0.28

ESR1 (AU)

-0.87 ± 0.33

-0.23

-2.65

0.0091

BMI (kg/m2)

0.07 ± 0.02

0.31

3.57

0.0005

Age (years)

-0.02 ± 0.02

-0.08

-1.00

0.32